Clinical trial
Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal…
NCT00184795 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184795 |
|---|---|
| Title | Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations |
| Official title | A Six Month Double-blind, Randomised, Parallel-group, Placebo-controlled, Multi-centre Trial to Investigate the Efficacy and Safety of Two Ultra-low Dose Combinations With 0.5 mg Estradiol and 0.1 mg or 0.25 mg Norethisterone Acetate (Activelle Low Dose 0.1/Activelle Low Dose 0.25) for Treatment of… |
| Acronym | CHOICE |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Menopausal Vasomotor Symptoms |
| Intervention type | Drug |
| Interventions | 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA), 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA), placebo |
| Enrollment | 576 |
| Start date | May 28, 2004 |
| Primary completion | May 4, 2005 |
| Completion | May 4, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 23, 2017 |
| Countries | Austria, Belgium, Denmark, Finland, France, Germany, Norway, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: